- Home
- VNDA vs IIF Comparison
VNDA vs IIF Comparison
Compare VNDA & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- IIF
- Stock Information
- Founded
- VNDA 2002
- IIF 1993
- Country
- VNDA United States
- IIF United States
- Employees
- VNDA N/A
- IIF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- IIF Trusts Except Educational Religious and Charitable
- Sector
- VNDA Health Care
- IIF Finance
- Exchange
- VNDA Nasdaq
- IIF Nasdaq
- Market Cap
- VNDA 249.4M
- IIF 270.7M
- IPO Year
- VNDA 2006
- IIF N/A
- Fundamental
- Price
- VNDA $4.75
- IIF $27.52
- Analyst Decision
- VNDA Strong Buy
- IIF
- Analyst Count
- VNDA 2
- IIF 0
- Target Price
- VNDA $16.50
- IIF N/A
- AVG Volume (30 Days)
- VNDA 551.9K
- IIF 45.4K
- Earning Date
- VNDA 07-31-2025
- IIF 01-01-0001
- Dividend Yield
- VNDA N/A
- IIF 13.94%
- EPS Growth
- VNDA N/A
- IIF N/A
- EPS
- VNDA N/A
- IIF N/A
- Revenue
- VNDA $203,467,000.00
- IIF N/A
- Revenue This Year
- VNDA $16.86
- IIF N/A
- Revenue Next Year
- VNDA $39.78
- IIF N/A
- P/E Ratio
- VNDA N/A
- IIF N/A
- Revenue Growth
- VNDA 11.78
- IIF N/A
- 52 Week Low
- VNDA $3.81
- IIF $18.95
- 52 Week High
- VNDA $5.55
- IIF $24.41
- Technical
- Relative Strength Index (RSI)
- VNDA 60.39
- IIF 55.56
- Support Level
- VNDA $4.47
- IIF $27.42
- Resistance Level
- VNDA $4.88
- IIF $27.69
- Average True Range (ATR)
- VNDA 0.16
- IIF 0.23
- MACD
- VNDA 0.05
- IIF 0.09
- Stochastic Oscillator
- VNDA 82.43
- IIF 83.17
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.